Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors-Reference-Cited by-同舟云学术

Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors

Published:2017-10 Issue:10 Volume:28 Page:833-841
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Ehrke-Schulz Eric¹,Zhang Wenli¹,Gao Jian¹,Ehrhardt Anja¹

Affiliation:

1. Chair for Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), Department for Human Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2017.140

Reference65 articles.

1. Persistence of High-Capacity Adenoviral Vectors as Replication-Defective Monomeric GenomesIn Vitroand in Murine Liver

2. Adenovirus: The First EffectiveIn VivoGene Delivery Vector

3. In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted

4. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

5. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade;Biomedicine & Pharmacotherapy;2023-05

2. A one-step construction of adenovirus (OSCA) system using the Gibson DNA Assembly technology;Molecular Therapy - Oncolytics;2021-12

3. Engineering precision therapies: lessons and motivations from the clinic;Synthetic Biology;2020-11-24

4. Methods to edit T cells for cancer immunotherapy;Methods in Enzymology;2020

5. Establishment of a Parvovirus B19 NS1-Expressing Recombinant Adenoviral Vector for Killing Megakaryocytic Leukemia Cells;Viruses;2019-09-04